Development and potential of a biomimetic chitosan/type II collagen scaffold for cartilage tissue engineering
- PMID: 16157047
Development and potential of a biomimetic chitosan/type II collagen scaffold for cartilage tissue engineering
Abstract
Background: Damaged articular cartilage has very limited capacity for spontaneous healing. Tissue engineering provides a new hope for functional cartilage repair. Creation of an appropriate cell carrier is one of the critical steps for successful tissue engineering. With the supposition that a biomimetic construct might promise to generate better effects, we developed a novel composite scaffold and investigated its potential for cartilage tissue engineering.
Methods: Chitosan of 88% deacetylation was prepared via a modified base reaction procedure. A freeze-drying process was employed to fabricate a three-dimensional composite scaffold consisting of chitosan and type II collagen. The scaffold was treated with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide. Ultrastructure and tensile strength of the matrix were carried out to assess its physico-chemical properties. After subcutaneous implantation in rabbits, its in vivo biocompatibility and degradability of the scaffold were determined. Its capacity to sustain chondrocyte growth and biosynthesis was evaluated through cell-scaffold co-culture in vitro.
Results: The fabricated composite matrix was porous and sponge-like with interconnected pores measuring from 100-250 microm in diameter. After cross-linking, the scaffold displayed enhanced tensile strength. Subcutaneous implantation results indicated the composite matrix was biocompatible and biodegradable. In intro cell-scaffold culture showed the scaffold sustained chondrocyte proliferation and differentiation, and maintained the spheric chondrocytic phenotype. As indicated by immunohistochemical staining, the chondrocytes synthesized type II collagen.
Conclusions: Chitosan and type II collagen can be well blended and developed into a porous 3-D biomimetic matrix. Results of physico-chemical and biological tests suggest the composite matrix satisfies the constraints specified for a tissue-engineered construct and may be used as a chondrocyte carrier for cartilage tissue engineering.
Similar articles
-
[Fabrication and properties of a composite chitosan/type II collagen scaffold for tissue engineering cartilage].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005 Apr;19(4):278-82. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005. PMID: 15921318 Chinese.
-
[Preparation and biocompatibility evaluation of novel cartilage acellular matrix sponge].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Aug;23(8):1002-6. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009. PMID: 19728622 Chinese.
-
The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering.J Biomed Mater Res A. 2010 Feb;92(2):712-23. doi: 10.1002/jbm.a.32198. J Biomed Mater Res A. 2010. PMID: 19274722
-
[Application of acellular matrix in cartilage tissue engineering].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Apr;23(4):501-4. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009. PMID: 19431995 Review. Chinese.
-
[Recent progress of researches in cartilage tissue engineering].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011 Feb;25(2):187-92. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011. PMID: 21427848 Review. Chinese.
Cited by
-
Optimum combination of insulin-transferrin-selenium and fetal bovine serum for culture of rabbit articular chondrocytes in three-dimensional alginate scaffolds.Int J Cell Biol. 2009;2009:747016. doi: 10.1155/2009/747016. Epub 2009 May 27. Int J Cell Biol. 2009. PMID: 20130769 Free PMC article.
-
Removal of collagen three-dimensional scaffold bubbles utilizing a vacuum suction technique.Cell Tissue Bank. 2023 Mar;24(1):181-190. doi: 10.1007/s10561-022-10020-w. Epub 2022 Jul 6. Cell Tissue Bank. 2023. PMID: 35794499
-
Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation.PLoS One. 2013 Jul 23;8(7):e69950. doi: 10.1371/journal.pone.0069950. Print 2013. PLoS One. 2013. PMID: 23894564 Free PMC article.
-
Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.Aging Dis. 2013 Dec 17;5(6):394-405. doi: 10.14336/AD.2014.0500394. eCollection 2014 Dec. Aging Dis. 2013. PMID: 25489490 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials